With the advancements in noninvasive cosmetic surgery, we have seen many innovative options to freeze our wrinkles, smooth our fine lines and erase our skin imperfections. However, double chin which is one of the most common aesthetic complaints, couldn’t be addressed with any of these non-invasive techniques. One had to go under the knife or at least needed an incision to improve the condition. However, good news is here now with the FDA approving an innovative wattle-reducing injection to resolve double chin.
According to the report published in cbsnews, the new injection which was earlier called ATX-101 and now named Kybella has been approved by the FDA to treat double chin. It consists of deoxycholic acid, a chemical that is naturally produced by the body and helps it absorb fats. It is injected into the skin to target and remove fat cells under the chin without spreading to nearby tissue. Fat cells are destroyed by breaking down the cell membrane. Kythera Biopharmaceuticals Inc. is the maker of this injection, which is bound to make big waves in the world of cosmetic surgery. The injections are expected to be available by the latter half of 2015.
According to an official of Facial Plastic Surgery & Reconstructive Surgery Academy (AAFPRS), “The ideal candidate is a younger individual with good skin elasticity and a milder double chin — it’s not going to replace a lift yet.”
A report published in abcnews said the injection has been the subject of 19 clinical studies involving 2,600 patients.
A full course of treatments can last for six months and entail multiple injections each month. The injections will be spaced no less than a month apart. Many patients who underwent the treatment experienced meaningful improvement in 2 – 4 treatments. As per the researchers, the fat cells are actually destroyed and so results are expected to be long-lasting or even permanent. Studies show that patients saw the changes lasting for at least two years.